aluates Reports

$ 0.0

Automative

Global Gene Therapy for Mucopolysaccharidosis Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-3B13530

Global Gene Therapy for Mucopolysaccharidosis Market Research Report 2023

BUY CHAPTERS

Global Gene Therapy for Mucopolysaccharidosis Market Research Report 2025

Code: QYRE-Auto-3B13530

Report

September 2025

Pages:69

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sangamo Therapeutics

Swedish Orphan Biovitrum

Uniqure

Gene Therapy for Mucopolysaccharidosis Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gene Therapy for Mucopolysaccharidosis Market

The global market for Gene Therapy for Mucopolysaccharidosis was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All of the mucopolysaccharidoses are rare, autosomal recessive, except for mucopolysaccharidosis III, as it is X-linked.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gene Therapy for Mucopolysaccharidosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy for Mucopolysaccharidosis.

The Gene Therapy for Mucopolysaccharidosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapy for Mucopolysaccharidosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Therapy for Mucopolysaccharidosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Therapy for Mucopolysaccharidosis Market Report

Report Metric	Details
Report Name	Gene Therapy for Mucopolysaccharidosis Market
CAGR	5%
Segment by Type	Intravenous ICV Intracerebral Intracisternal
Segment by Application	Mucopolysaccharidosis I Mucopolysaccharidosis II Mucopolysaccharidosis III A Mucopolysaccharidosis III B
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sangamo Therapeutics, Swedish Orphan Biovitrum, uniQure
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy for Mucopolysaccharidosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Therapy for Mucopolysaccharidosis Market report?

Ans: The main players in the Gene Therapy for Mucopolysaccharidosis Market are Sangamo Therapeutics, Swedish Orphan Biovitrum, uniQure

What are the Application segmentation covered in the Gene Therapy for Mucopolysaccharidosis Market report?

Ans: The Applications covered in the Gene Therapy for Mucopolysaccharidosis Market report are Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis III A, Mucopolysaccharidosis III B

What are the Type segmentation covered in the Gene Therapy for Mucopolysaccharidosis Market report?

Ans: The Types covered in the Gene Therapy for Mucopolysaccharidosis Market report are Intravenous, ICV, Intracerebral, Intracisternal

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapy for Mucopolysaccharidosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Intravenous

1.2.3 ICV

1.2.4 Intracerebral

1.2.5 Intracisternal

1.3 Market by Application

1.3.1 Global Gene Therapy for Mucopolysaccharidosis Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Mucopolysaccharidosis I

1.3.3 Mucopolysaccharidosis II

1.3.4 Mucopolysaccharidosis III A

1.3.5 Mucopolysaccharidosis III B

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Therapy for Mucopolysaccharidosis Market Perspective (2020-2031)

2.2 Global Gene Therapy for Mucopolysaccharidosis Growth Trends by Region

2.2.1 Global Gene Therapy for Mucopolysaccharidosis Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gene Therapy for Mucopolysaccharidosis Historic Market Size by Region (2020-2025)

2.2.3 Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Region (2026-2031)

2.3 Gene Therapy for Mucopolysaccharidosis Market Dynamics

2.3.1 Gene Therapy for Mucopolysaccharidosis Industry Trends

2.3.2 Gene Therapy for Mucopolysaccharidosis Market Drivers

2.3.3 Gene Therapy for Mucopolysaccharidosis Market Challenges

2.3.4 Gene Therapy for Mucopolysaccharidosis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Therapy for Mucopolysaccharidosis Players by Revenue

3.1.1 Global Top Gene Therapy for Mucopolysaccharidosis Players by Revenue (2020-2025)

3.1.2 Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Players (2020-2025)

3.2 Global Gene Therapy for Mucopolysaccharidosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gene Therapy for Mucopolysaccharidosis Revenue

3.4 Global Gene Therapy for Mucopolysaccharidosis Market Concentration Ratio

3.4.1 Global Gene Therapy for Mucopolysaccharidosis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Mucopolysaccharidosis Revenue in 2024

3.5 Global Key Players of Gene Therapy for Mucopolysaccharidosis Head office and Area Served

3.6 Global Key Players of Gene Therapy for Mucopolysaccharidosis, Product and Application

3.7 Global Key Players of Gene Therapy for Mucopolysaccharidosis, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy for Mucopolysaccharidosis Breakdown Data by Type

4.1 Global Gene Therapy for Mucopolysaccharidosis Historic Market Size by Type (2020-2025)

4.2 Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Type (2026-2031)

5 Gene Therapy for Mucopolysaccharidosis Breakdown Data by Application

5.1 Global Gene Therapy for Mucopolysaccharidosis Historic Market Size by Application (2020-2025)

5.2 Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gene Therapy for Mucopolysaccharidosis Market Size (2020-2031)

6.2 North America Gene Therapy for Mucopolysaccharidosis Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2020-2025)

6.4 North America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Therapy for Mucopolysaccharidosis Market Size (2020-2031)

7.2 Europe Gene Therapy for Mucopolysaccharidosis Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Country (2020-2025)

7.4 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size (2020-2031)

8.2 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Region (2020-2025)

8.4 Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Therapy for Mucopolysaccharidosis Market Size (2020-2031)

9.2 Latin America Gene Therapy for Mucopolysaccharidosis Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2020-2025)

9.4 Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size (2020-2031)

10.2 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Country (2020-2025)

10.4 Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sangamo Therapeutics

11.1.1 Sangamo Therapeutics Company Details

11.1.2 Sangamo Therapeutics Business Overview

11.1.3 Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Introduction

11.1.4 Sangamo Therapeutics Revenue in Gene Therapy for Mucopolysaccharidosis Business (2020-2025)

11.1.5 Sangamo Therapeutics Recent Development

11.2 Swedish Orphan Biovitrum

11.2.1 Swedish Orphan Biovitrum Company Details

11.2.2 Swedish Orphan Biovitrum Business Overview

11.2.3 Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Introduction

11.2.4 Swedish Orphan Biovitrum Revenue in Gene Therapy for Mucopolysaccharidosis Business (2020-2025)

11.2.5 Swedish Orphan Biovitrum Recent Development

11.3 uniQure

11.3.1 uniQure Company Details

11.3.2 uniQure Business Overview

11.3.3 uniQure Gene Therapy for Mucopolysaccharidosis Introduction

11.3.4 uniQure Revenue in Gene Therapy for Mucopolysaccharidosis Business (2020-2025)

11.3.5 uniQure Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sangamo Therapeutics

Swedish Orphan Biovitrum

Uniqure

List of Tables

Table 1. Global Gene Therapy for Mucopolysaccharidosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Intravenous

Table 3. Key Players of ICV

Table 4. Key Players of Intracerebral

Table 5. Key Players of Intracisternal

Table 6. Global Gene Therapy for Mucopolysaccharidosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Gene Therapy for Mucopolysaccharidosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Gene Therapy for Mucopolysaccharidosis Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Gene Therapy for Mucopolysaccharidosis Market Share by Region (2020-2025)

Table 10. Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Gene Therapy for Mucopolysaccharidosis Market Share by Region (2026-2031)

Table 12. Gene Therapy for Mucopolysaccharidosis Market Trends

Table 13. Gene Therapy for Mucopolysaccharidosis Market Drivers

Table 14. Gene Therapy for Mucopolysaccharidosis Market Challenges

Table 15. Gene Therapy for Mucopolysaccharidosis Market Restraints

Table 16. Global Gene Therapy for Mucopolysaccharidosis Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Gene Therapy for Mucopolysaccharidosis Market Share by Players (2020-2025)

Table 18. Global Top Gene Therapy for Mucopolysaccharidosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Mucopolysaccharidosis as of 2024)

Table 19. Ranking of Global Top Gene Therapy for Mucopolysaccharidosis Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Gene Therapy for Mucopolysaccharidosis Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Gene Therapy for Mucopolysaccharidosis, Headquarters and Area Served

Table 22. Global Key Players of Gene Therapy for Mucopolysaccharidosis, Product and Application

Table 23. Global Key Players of Gene Therapy for Mucopolysaccharidosis, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Gene Therapy for Mucopolysaccharidosis Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Type (2020-2025)

Table 27. Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Type (2026-2031)

Table 29. Global Gene Therapy for Mucopolysaccharidosis Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Application (2020-2025)

Table 31. Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Application (2026-2031)

Table 33. North America Gene Therapy for Mucopolysaccharidosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Gene Therapy for Mucopolysaccharidosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Gene Therapy for Mucopolysaccharidosis Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Gene Therapy for Mucopolysaccharidosis Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Gene Therapy for Mucopolysaccharidosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size by Country (2026-2031) & (US$ Million)

Table 48. Sangamo Therapeutics Company Details

Table 49. Sangamo Therapeutics Business Overview

Table 50. Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Product

Table 51. Sangamo Therapeutics Revenue in Gene Therapy for Mucopolysaccharidosis Business (2020-2025) & (US$ Million)

Table 52. Sangamo Therapeutics Recent Development

Table 53. Swedish Orphan Biovitrum Company Details

Table 54. Swedish Orphan Biovitrum Business Overview

Table 55. Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Product

Table 56. Swedish Orphan Biovitrum Revenue in Gene Therapy for Mucopolysaccharidosis Business (2020-2025) & (US$ Million)

Table 57. Swedish Orphan Biovitrum Recent Development

Table 58. uniQure Company Details

Table 59. uniQure Business Overview

Table 60. uniQure Gene Therapy for Mucopolysaccharidosis Product

Table 61. uniQure Revenue in Gene Therapy for Mucopolysaccharidosis Business (2020-2025) & (US$ Million)

Table 62. uniQure Recent Development

Table 63. Research Programs/Design for This Report

Table 64. Key Data Information from Secondary Sources

Table 65. Key Data Information from Primary Sources

Table 66. Authors List of This Report

List of Figures

Figure 1. Gene Therapy for Mucopolysaccharidosis Picture

Figure 2. Global Gene Therapy for Mucopolysaccharidosis Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gene Therapy for Mucopolysaccharidosis Market Share by Type: 2024 VS 2031

Figure 4. Intravenous Features

Figure 5. ICV Features

Figure 6. Intracerebral Features

Figure 7. Intracisternal Features

Figure 8. Global Gene Therapy for Mucopolysaccharidosis Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Gene Therapy for Mucopolysaccharidosis Market Share by Application: 2024 VS 2031

Figure 10. Mucopolysaccharidosis I Case Studies

Figure 11. Mucopolysaccharidosis II Case Studies

Figure 12. Mucopolysaccharidosis III A Case Studies

Figure 13. Mucopolysaccharidosis III B Case Studies

Figure 14. Gene Therapy for Mucopolysaccharidosis Report Years Considered

Figure 15. Global Gene Therapy for Mucopolysaccharidosis Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Gene Therapy for Mucopolysaccharidosis Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Gene Therapy for Mucopolysaccharidosis Market Share by Region: 2024 VS 2031

Figure 18. Global Gene Therapy for Mucopolysaccharidosis Market Share by Players in 2024

Figure 19. Global Top Gene Therapy for Mucopolysaccharidosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Mucopolysaccharidosis as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Gene Therapy for Mucopolysaccharidosis Revenue in 2024

Figure 21. North America Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Gene Therapy for Mucopolysaccharidosis Market Share by Country (2020-2031)

Figure 23. United States Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Gene Therapy for Mucopolysaccharidosis Market Share by Country (2020-2031)

Figure 27. Germany Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Gene Therapy for Mucopolysaccharidosis Market Share by Region (2020-2031)

Figure 35. China Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Gene Therapy for Mucopolysaccharidosis Market Share by Country (2020-2031)

Figure 43. Mexico Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Gene Therapy for Mucopolysaccharidosis Market Share by Country (2020-2031)

Figure 47. Turkey Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Sangamo Therapeutics Revenue Growth Rate in Gene Therapy for Mucopolysaccharidosis Business (2020-2025)

Figure 51. Swedish Orphan Biovitrum Revenue Growth Rate in Gene Therapy for Mucopolysaccharidosis Business (2020-2025)

Figure 52. uniQure Revenue Growth Rate in Gene Therapy for Mucopolysaccharidosis Business (2020-2025)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-33R16806

Tue Nov 11 00:00:00 UTC 2025

Add to Cart

Global Lysosomal Storage Disease Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17R1241

Mon Sep 15 00:00:00 UTC 2025

Add to Cart

Global Klippel Trenaunay Syndrome Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20L1035

Mon Sep 15 00:00:00 UTC 2025

Add to Cart

Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24R5886

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Gene Therapy for Mucopolysaccharidosis Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-3B13530

Global Gene Therapy for Mucopolysaccharidosis Market Research Report 2025

FEATURED COMPANIES

Gene Therapy for Mucopolysaccharidosis Market Size

Gene Therapy for Mucopolysaccharidosis Market

Scope of Gene Therapy for Mucopolysaccharidosis Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Gene Therapy for Mucopolysaccharidosis Market report?

What are the Application segmentation covered in the Gene Therapy for Mucopolysaccharidosis Market report?

What are the Type segmentation covered in the Gene Therapy for Mucopolysaccharidosis Market report?

FEATURED COMPANIES

RELATED REPORTS